Caladrius Biosciences (NASDAQ:CLBS) and Pacific Health Care Organization (OTCMKTS:PFHOD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends.
Analyst Recommendations
This is a summary of current ratings and recommmendations for Caladrius Biosciences and Pacific Health Care Organization, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Caladrius Biosciences | 0 | 1 | 3 | 0 | 2.75 |
Pacific Health Care Organization | 0 | 0 | 0 | 0 | N/A |
Caladrius Biosciences presently has a consensus target price of $10.00, indicating a potential upside of 553.59%. Given Caladrius Biosciences' higher probable upside, equities analysts clearly believe Caladrius Biosciences is more favorable than Pacific Health Care Organization.
Earnings & Valuation
This table compares Caladrius Biosciences and Pacific Health Care Organization's gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Caladrius Biosciences | N/A | N/A | $-19,360,000.00 | ($1.88) | -0.81 |
Pacific Health Care Organization | $6.80 million | 2.35 | $1.36 million | N/A | N/A |
Pacific Health Care Organization has higher revenue and earnings than Caladrius Biosciences.
Risk and Volatility
Caladrius Biosciences has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500. Comparatively, Pacific Health Care Organization has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500.
Profitability
This table compares Caladrius Biosciences and Pacific Health Care Organization's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Caladrius Biosciences | N/A | -68.33% | -57.61% |
Pacific Health Care Organization | 16.87% | 14.47% | 12.96% |
Institutional and Insider Ownership
9.0% of Caladrius Biosciences shares are held by institutional investors. 10.3% of Caladrius Biosciences shares are held by insiders. Comparatively, 61.6% of Pacific Health Care Organization shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Pacific Health Care Organization beats Caladrius Biosciences on 6 of the 10 factors compared between the two stocks.